In a study by Ibarra-Lecue et al. (2018), activation of the Akt/mTOR pathway exacerbated schizophrenia-like responses in a tetrahydrocannabinol-induced mouse model of schizophrenia (10 mg/kg i.p.). The gene discussed is AKT1; the disease is schizophrenia.